Results 61 to 70 of about 260,112 (235)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011

open access: yesEmerging Infectious Diseases, 2015
Drug-resistant Mycobacterium tuberculosis is challenging elimination of tuberculosis (TB). We evaluated risk factors for TB and levels of second-line drug resistance in M. tuberculosis in patients in Europe with multidrug-resistant (MDR) TB.
Gunar Günther   +29 more
doaj   +1 more source

Development and Validation of Urodynamic Report Writer: A Chat GPT App

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Objective Accurate interpretation and reporting of urodynamic studies are essential for diagnosis and management of lower urinary tract dysfunction, yet remain time‐consuming and operator‐dependent. To develop and validate the Urodynamic Report Writer App (URapp), a GPT‐4o‐based virtual assistant that supports interpretation of clinician ...
Riccardo Lombardo   +16 more
wiley   +1 more source

The Development Of A Candidate Tuberclosis DNA Vaccine Expressing Mtb8.4 And Ag85B of Mycobacterium Tuberclosis [RA644.T7 M393 2007 f rb]. [PDF]

open access: yes, 2007
Tuberculosis (TB) is still one of the major health problems worldwide. The only TB vaccine currently available is an attenuated strain of Mycobacterium bovis, bacille Calmette Guerin (BCG). However, the efficacy of BCG vaccine continues to be debated.
Azlan, Maryam
core   +1 more source

The Paediatric BCG Vaccine Century: From Historical Success to Future Innovations

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim The tuberculosis (TB) vaccine, Bacille‐Calmette‐Guérin (BCG), protects infants against severe forms of primary TB. Yet, it does not protect against pulmonary reactivation TB in adults. Methods A literature review was conducted between 1st January and 28th February 2025 using PubMed, Google Scholar and reports of the World Health ...
Stefan H. E. Kaufmann
wiley   +1 more source

Prevalence of Pre-Extensively Drug-Resistant Tuberculosis (Pre XDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Center in Mumbai [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2016
Background: India is a high burden country for Tuberculosis (TB). As per the World Health Organization (WHO) statistics, 24000 cases of Multi Drug Resistant (MDR) TB were diagnosed in India in 2014.
Unnati D. Desai , Jyotsna M. Joshi
doaj  

Patterns of Drug Resistance, Drug Resistance Conferring Mutations and Genomic DNA Methylation Revealed in Mycobacterium tuberculosis From South Africa

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Tuberculosis remains a major public health threat globally, with drug‐resistant strains undermining treatment efficacy. We analyzed 126 Mycobacterium tuberculosis (M. tuberculosis) isolates with diverse drug resistance spectra and selected 35 for whole genome sequencing (WGS) using Illumina NextSeq, SMRT PacBio Onso and SMRT PacBio Revio ...
Unarine Matodzi   +5 more
wiley   +1 more source

A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, São Paulo, Brazil

open access: yesMemorias do Instituto Oswaldo Cruz, 2012
Monitoring the extent of and trends in multidrug-resistant tuberculosis (MDR-TB) is a priority of the Brazilian National Tuberculosis Control Programme.
Andréa Gobetti Vieira Coelho   +4 more
doaj   +1 more source

Effect of Green‐Synthesized Silver Nanoparticles From Nepeta pogonosperma and Astrodaucus persicus on the Reduction of Bap Gene Expression in Strong Biofilm‐Producing Acinetobacter baumannii Clinical Isolates

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
Green‐synthesized silver nanoparticles from Nepeta pogonosperma and Astrodaucus persicus significantly inhibit biofilm formation and downregulate bap gene expression in multidrug‐resistant clinical isolates of Acinetobacter baumannii. This eco‐friendly approach offers a promising strategy to combat antimicrobial resistance.
Maedeh Kakavan   +6 more
wiley   +1 more source

MDR-TB-related costs incurred during treatment.

open access: yes
BackgroundWe compared the cost-consequence of a home-based multidrug-resistant tuberculosis (MDR-TB) model of care, based on task-shifting of directly observed therapy (DOT) and MDR-TB injection administration to lay health workers, to a routine clinic ...
J. Christo Heunis (13046945)   +3 more
core   +1 more source

MDR TB [PDF]

open access: yes
Tuberculosis (TB) is a disease caused by bacteria that are spread from person to person through the air. TB usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) Division of Tuberculosis Elimination.
core   +2 more sources

Home - About - Disclaimer - Privacy